Your session is about to expire
← Back to Search
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
Study Summary
This trial will test if it is just as effective to give a higher dose of radiation in 10 treatments as it is to give a lower dose of radiation in 25 treatments for Merkel cell carcinoma patients receiving immunotherapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2013 Phase 3 trial • 397 Patients • NCT00004054Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am capable of limited self-care.I had a positive lymph node biopsy and am planning radiation therapy without full lymph node removal.My cancer has spread to distant parts of my body.I had surgery to remove my primary MCC tumor less than 4 months ago and am planning radiation therapy.I have another cancer type, but it won't affect this trial's treatment.I've had radiation before in the same area where my current cancer needs treatment.I can receive immunotherapy before, during, or after radiation therapy.Patients must have a confirmed diagnosis of Merkel cell carcinoma through tissue or cell samples.My cancer has not spread to distant parts of my body as confirmed by tests.I am 18 years old or older.I agree to use birth control during the study.I am under 18 years old.
- Group 1: Radiation therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA ratified radiation therapy as a viable treatment?
"Owing to the second-phase nature of this trial, which has produced data indicating safety but not efficacy, our team at Power estimated Radiation therapy's security rating as a 2."
Are there any opportunities for participants to join this experiment?
"Clinicaltrials.gov indicates that this medical trial is currently enlisting patients, with the posting date being December 14th 2021 and the most recent modification occurring on February 3rd 2022."
What is the aggregate figure of individuals involved in this research project?
"Affirmative. The information displayed on clinicaltrials.gov confirms that the medical study, which was first posted on December 14th 2021, is actively searching for patients. Approximately 52 participants need to be found from a single healthcare facility."
Share this study with friends
Copy Link
Messenger